GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Stock Based Compensation

Alto Neuroscience (Alto Neuroscience) Stock Based Compensation : $2.79 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Stock Based Compensation?

Alto Neuroscience's Stock Based Compensation for the three months ended in Mar. 2024 was $2.18 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was $2.79 Mil.


Alto Neuroscience Stock Based Compensation Historical Data

The historical data trend for Alto Neuroscience's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Stock Based Compensation Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Stock Based Compensation
0.23 1.76 2.89

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial 0.94 0.48 - 0.61 2.18

Alto Neuroscience Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.79 Mil.


Alto Neuroscience Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Alto Neuroscience (Alto Neuroscience) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus